Option Care Health, Inc 8-K, filed Sep 22, 2021
Option Care Health, Inc. (OPCH)
8-K
2021-09-22
For: 2021-09-17
View Original
Added on
April 05, 2026
About this 8-K
Option Care Health, Inc filed this 8-K on September 22, 2021, reporting on events of September 17, 2021.
Items reported
- Item 5.02: Director or officer change, or executive pay
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
_____________________
(Exact name of registrant as specified in its charter)
_____________________
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
(Address of principal executive offices)
(312 ) 940-2443
(Registrant's telephone number, including area code)
_____________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each Class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act. ¨
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On September 17, 2021, Clifford Berman, Senior Vice President, General Counsel and Corporate Secretary of Option Care Health, Inc. (the “Company”), notified the Company that he intends to retire on March 31, 2022.
Mr. Berman, age 62, will continue in his current duties through the end of March, 2022, while the Company engages an executive search firm to identify his successor. Mr. Berman has been a member of the Company’s executive leadership team for six years and has been instrumental in the Company’s success after separating from Walgreens in April 2015. Mr. Berman will retire following a 39-year career, starting as a pharmacist with Walgreens and subsequently as legal counsel at several leading health care companies, including Baxter, Caremark, Allscripts, Abbott Laboratories, and Catamaran.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Option Care Health, Inc. | |||||||||||
| Date: | September 22, 2021 | By: | /s/ Michael Shapiro | ||||||||
| Name: | Michael Shapiro | ||||||||||
| Title: | Chief Financial Officer | ||||||||||